Burkitt's lymphoma risk factors

Revision as of 04:48, 18 January 2019 by Skazmi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Burkitt's lymphoma Microchapters


Patient Information


Historical Perspective




Differentiating Burkitt's lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study Of Choice


History and Symptoms

Physical Examination

Laboratory Findings

X Ray Findings




Other Imaging Studies

Other Diagnostic Studies


Medical Therapy


Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Burkitt's lymphoma risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Burkitt's lymphoma risk factors

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Burkitt's lymphoma risk factors

CDC on Burkitt's lymphoma risk factors

Burkitt's lymphoma risk factors in the news

Blogs on Burkitt's lymphoma risk factors

Directions to Hospitals Treating Burkitt's lymphoma

Risk calculators and risk factors for Burkitt's lymphoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]


Common risk factors in the development of Burkitt's lymphoma are HIV/AIDS and post-transplant immunosuppression. There are no established risk factors for childhood Burkitt's lymphoma.

Risk Factors

Common risk factors in the development of Burkitt's lymphoma may include:[1]


  1. 1.0 1.1 Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN; et al. (2018). "Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink". Br J Haematol. 181 (4): 505–514. doi:10.1111/bjh.15229. PMC 5980720. PMID 29676453.
  2. Meister A, Hentrich M, Wyen C, Hübel K (2018). "Malignant lymphoma in the HIV-positive patient". Eur J Haematol. 101 (1): 119–126. doi:10.1111/ejh.13082. PMID 29663523.
  3. Naik S, Tayapongsak K, Robbins K, Manavi CK, Pettenati MJ, Grier DD (2013). "Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature". Case Rep Oncol. 6 (1): 6–14. doi:10.1159/000346346. PMC 3573821. PMID 23466659.
  4. Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD; et al. (2013). "Burkitt lymphoma risk in U.S. solid organ transplant recipients". Am J Hematol. 88 (4): 245–50. doi:10.1002/ajh.23385. PMC 3608801. PMID 23386365.

Template:WikiDoc Sources